Skip to content

Clinical trials

Completed Lung Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Status: Completed Country / region: United States Clear all

233 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20025
20038
20049
200512
20068
20073
20086
200915
20105
20114
20129
201313
201415
201513
201614
201711
20189
201912
202010
202111
20226
202310
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed233

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca22
National Heart, Lung, and Blood Institute (NHLBI)7
Columbia University6
NYU Langone Health6
Novartis Pharmaceuticals6
University of Pittsburgh6
Johns Hopkins University5
University of Wisconsin, Madison5
Weill Medical College of Cornell University5
National Institute of Environmental Health Sciences (NIEHS)4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases233
Respiratory Tract Diseases51
Asthma47
Pulmonary Disease, Chronic Obstructive46
Lung Diseases, Obstructive30
Bronchial Diseases23
Lung Neoplasms20
Neoplasms19
Cystic Fibrosis16
Emphysema14

Trials

Showing 1 to 25 of 233. Each trial links to its page on Pharma Observatory.

133 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.